Correction: A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis

Affiliations

• ¹ Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
• ² Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. charlotte.ockeloen@radboudumc.nl.
• ³ CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
• ⁴ Department of Clinical Neurosciences, University of Cambridge, John Van Geest Cambridge Centre for Brain Repair, Cambridge, UK.
• ⁵ Department of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁶ Department of Human Genetics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁷ Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁸ Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁹ Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
• ¹⁰ Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
• ¹¹ MRGM, Maladies Rares: Génétique et Métabolisme, lNSERM U1211, Université de Bordeaux, Bordeaux, France.
• ¹² Département de Génétique, APHP Robert DEBRE University Hospital and INSERM U1141, Paris, France.